Gene expression changes in SS, such as decreased expression of IFN-γ, and increased expression of unique biomarker genes identified in SS such as TWIST1, and TOX are frequent and represent important features of CTCL [13–15]. The gene discussed is TOX; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.